<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink">
	
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">elife</journal-id>
			<journal-id journal-id-type="hwp">eLife</journal-id>
			<journal-id journal-id-type="publisher-id">eLife</journal-id>
			<journal-title-group>
				<journal-title>eLife</journal-title>
			</journal-title-group>
			<issn pub-type="epub">2050-084X</issn>
			<publisher>
				<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">01936</article-id>
			<article-id pub-id-type="doi">10.7554/eLife.01936</article-id>
			<article-categories>
				<subj-group subj-group-type="display-channel">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="heading">
					<subject>Neuroscience</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author" id="author-8294">
					<name>
						<surname>Tritsch</surname>
						<given-names>Nicolas X</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Neurobiology</named-content>
						</addr-line>
						, 
						<institution>Howard Hughes Medical Institute, Harvard Medical School</institution>
						, 
						<addr-line>
							<named-content content-type="city">Boston</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" id="author-9211">
					<name>
						<surname>Oh</surname>
						<given-names>Won-Jong</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Neurobiology</named-content>
						</addr-line>
						, 
						<institution>Harvard Medical School</institution>
						, 
						<addr-line>
							<named-content content-type="city">Boston</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" id="author-9212">
					<name>
						<surname>Gu</surname>
						<given-names>Chenghua</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Neurobiology</named-content>
						</addr-line>
						, 
						<institution>Harvard Medical School</institution>
						, 
						<addr-line>
							<named-content content-type="city">Boston</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" corresp="yes" id="author-9170">
					<name>
						<surname>Sabatini</surname>
						<given-names>Bernardo L</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Neurobiology</named-content>
						</addr-line>
						, 
						<institution>Howard Hughes Medical Institute, Harvard Medical School</institution>
						, 
						<addr-line>
							<named-content content-type="city">Boston</named-content>
						</addr-line>
						, 
						<country>United States</country>
						<email>bsabatini@hms.harvard.edu</email>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
			</contrib-group>
			<contrib-group content-type="section">
				<contrib contrib-type="editor" id="author-1202">
					<name>
						<surname>Westbrook</surname>
						<given-names>Gary L</given-names>
					</name>
					<role>Reviewing editor</role>
					<aff>
						<institution>Vollum Institute</institution>
						, 
						<country>United States</country>
					</aff>
				</contrib>
			</contrib-group>
			<pub-date date-type="pub" publication-format="electronic"><day>24</day><month>04</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e01936</elocation-id>
			<supplementary-material><ext-link xlink:href="elife-01936-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history>
				<date date-type="received">
					<day>22</day>
					<month>11</month>
					<year>2013</year>
				</date>
				<date date-type="accepted">
					<day>25</day>
					<month>03</month>
					<year>2014</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright Â© 2014, Tritsch et al</copyright-statement>
				<copyright-year>2014</copyright-year>
				<copyright-holder>Tritsch et al</copyright-holder>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
					<license-p>
						This article is distributed under the terms of the 
						<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>
						, which permits unrestricted use and redistribution provided that the original author and source are credited.
					</license-p>
				</license>
			</permissions>
			<abstract>
				<p>Synaptic transmission between midbrain dopamine neurons and target neurons in the striatum is essential for the selection and reinforcement of movements. Recent evidence indicates that nigrostriatal dopamine neurons inhibit striatal projection neurons by releasing a neurotransmitter that activates GABAA receptors. Here we demonstrate that this phenomenon extends to mesolimbic afferents, and confirm that the released neurotransmitter is GABA. However, the GABA synthetic enzymes GAD65 and GAD67 are not detected in midbrain dopamine neurons. Instead, these cells express the membrane GABA transporters mGAT1 (Slc6a1) and mGAT4 (Slc6a11) and inhibition of these transporters prevents GABA co-release. These findings therefore indicate that GABA co-release is a general feature of midbrain dopaminergic neurons that relies on GABA uptake from the extracellular milieu as opposed to de novo synthesis. This atypical mechanism may confer dopaminergic neurons the flexibility to differentially control GABAergic transmission in a target-dependent manner across their extensive axonal arbors.</p>
			</abstract>
			<kwd-group kwd-group-type="research-organism">
				<title>Research organism</title>
				<kwd>Mouse</kwd></kwd-group>
		</article-meta>
	</front>
	<back>
		<fn-group content-type="competing-interest">
			<title>Competing interest</title>
			<fn fn-type="conflict" id="conf1">
				<p>The authors declare that no competing interests exist.</p>
			</fn>
		</fn-group>
		<fn-group content-type="ethics-information">
			<title>Ethics</title>
			<fn fn-type="other">
				<p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All experimental manipulations were performed in accordance with protocols approved by the Harvard Medical Area Standing Committee on Animal Care (#03551).</p>
			</fn>
		</fn-group>
	</back>
</article>